updates on the use of molecular monitoring to detect mrd in aml
Published 10 months ago • 97 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
1:39
an insight into mrd monitoring and mrd-driven treatment in aml
-
2:22
next-generation methodologies: the future for mrd monitoring in all?
-
4:21
mrd as a monitoring technique of allosct and car-t in aml/all
-
1:23
the role of mrd status & the eln 2022 in predicting clinical outcomes of patients with aml
-
3:02
mrd monitoring by ngs in aml over time: revealing predictors of relapse
-
1:41
novel technologies to detect minimal residual disease (mrd)
-
1:05
identifying residual lscs that may evade standard mrd monitoring & lead to relapse in aml
-
3:13
is mrd monitoring prior to allograft standard in aml?
-
2:17
sirpα/cd47: don’t eat me!
-
1:48
bioexplore - cd47 in contact with sirp
-
8:58
oh-my-cron! covid-19 omicron variant - how afraid do we need to be?
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
1:23
the value of mrd as a marker for disease eradication in aml
-
1:46
standardization mrd monitoring in clinical trials
-
1:41
the future of aml and mds diagnosis and treatment
-
1:03
future considerations for mrd in aml
-
2:26
impact of allelic state on os in tp53-mutant aml and hr-mds
-
1:01
recent and future changes in the landscape of aml: the addition of venetoclax and mrd eradication
-
1:49
bringing precision medicine and mrd into clinical strategies
-
1:28
cd47 antibodies for the treatment of aml and mds: where is the field moving?
-
1:37
the importance of mrd assessment before allosct in all
-
1:41
mrd testing prior to allosct can predict os and dfs in aml